Newborn screening for sickle cell disease

This technology is proving to be cost-effective and competitive for the detection of sickle cell disease and other hemoglobinopathies in newborns. Here are 4 reasons to adopt this technique. Targeted, mass spectrometry selects only certain peptides of interest in hemoglobin. It therefore addresse...